Westinghouse Wins Competitive Bid for Delivery of Nuclear Fuel to Spain
Westinghouse Electric Company today announced the signing of a contract for manufacture and delivery of boiling water reactor (BWR) fuel to Cofrentes Nuclear Power Plant (CNC) in Spain in 2019 and 2021. CNC is wholly owned by Iberdrola Generación Nuclear S.A.
“The reliability and excellent performance of our fuel products are the main reasons for the continued trust Iberdrola has shown us. It also confirms our position as a leading supplier of BWR fuel in Europe,” says Aziz Dag, Westinghouse vice president and managing director, Northern Europe.
Westinghouse will deliver its extensively proven SVEA-96 Optima2 design, which has been operating flawlessly for more than a decade in CNC. Under the terms of the contract, CNC will also have the opportunity to implement TRITON11™, the latest BWR fuel innovation from Westinghouse. TRITON11 offers best-in-class uranium utilization, and is designed to give utilities the power to enhance the fuel economy and capacity factors.
“We are pleased to be able to continue the successful cooperation between our companies,” said Xavier Coll Sugrañes, Westinghouse vice president and managing director, Southern Europe.
The fuel will be manufactured at the Westinghouse fuel fabrication facility in Västerås, Sweden, which will also provide the included engineering and fuel services support.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
TAKEDA-PHARMACEUTICAL20.5.2019 02:18:06 CEST | Pressemeddelelse
New Exploratory Data from VARSITY, First Head-to-Head Ulcerative Colitis Biologic Study Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week®
TX-RESMED19.5.2019 21:17:12 CEST | Pressemeddelelse
Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought
WORKIVA17.5.2019 14:02:08 CEST | Pressemeddelelse
Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards
NOVAREMED17.5.2019 12:15:13 CEST | Pressemeddelelse
Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 2019
WIN-CONSORTIUM17.5.2019 11:40:10 CEST | Pressemeddelelse
WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology
NY-CORSEARCH17.5.2019 10:02:09 CEST | Pressemeddelelse
Corsearch Acquires Principium Trademark Watch and Domain Services Businesses
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum